Echocardiographic Assessment of the Impact of Diabetes and Prognostic Analysis of Heart Transplantation
NCT ID: NCT04976517
Last Updated: 2021-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2021-08-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Assessment of Impaired Cardiac Function in Patients With Diabetes Mellitus
NCT05484817
Single-center Clinical Study of Early Diagnosis of Diabetic Cardiomyopathy With FLIM
NCT04534894
Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
NCT07293338
CARdiomyopathy in Type 2 DIAbetes Mellitus
NCT04303364
Diabetic Cardiomyopathy
NCT04593173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-diabetes group
patients who underwent heart tranplantation without diabetes
No interventions assigned to this group
pre-transplant diabetes group
patients who underwent heart tranplantation with diabetes before the transplantation
No interventions assigned to this group
post transplant daibetes group
patients who underwent heart tranplantation without diabetes until after the transplantation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Shanghai Zhongshan Hospital
OTHER
Wuhan Asia Heart Hospital
OTHER
Guangdong Provincial People's Hospital
OTHER
Henan Provincial People's Hospital
OTHER
Xie Mingxing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xie Mingxing
MD, PhD,FACC, FAHA, FASE
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Zhang, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Ultrasound, Union Hospital, Wuhan, China
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021 v1.00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.